Cardiac Contractility Modulation (CCM) Therapy in Subjects With Medically Refractory Heart Failure (IMPULSE-HF)
Cardiac Contractility Modulation (CCM) Therapy in Subjects With Medically Refractory Heart Failure: A Randomized Efficacy Study
Sponsor: Impulse Dynamics
Terminated
Slow enrolment.
Other terminated trials from Impulse Dynamics
A NA clinical study on Heart Failure, this trial is terminated or withdrawn. The trial is conducted by Impulse Dynamics and has accumulated 9 data snapshots since 2014. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Terminated NA
-
Sep 2024 — Sep 2025 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Oct 2020 — Jan 2021 [monthly]
Terminated NA
▶ Show 4 earlier versions
-
Jun 2018 — Oct 2020 [monthly]
Terminated NA
-
Mar 2018 — Jun 2018 [monthly]
Terminated NA
-
Sep 2017 — Mar 2018 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Jan 2017 — Sep 2017 [monthly]
Recruiting NA
First recorded
Feb 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Impulse Dynamics
For direct contact, visit the study record on ClinicalTrials.gov .